Onyx Pharmaceuticals Debt to Equity Ratio:
0.1532 for Dec. 31, 2012Onyx Pharmaceuticals Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.1532 |
| Dec. 31, 2012 | 0.2127 |
| Sept. 30, 2012 | 0.2063 |
| June 30, 2012 | 0.2384 |
| March 31, 2012 | 0.2119 |
| Dec. 31, 2011 | 0.1978 |
| Sept. 30, 2011 | 0.2702 |
| June 30, 2011 | 0.2543 |
| March 31, 2011 | 0.2352 |
| Dec. 31, 2010 | 0.2189 |
| Sept. 30, 2010 | 0.213 |
| June 30, 2010 | 0.2257 |
| March 31, 2010 | 0.1952 |
| Dec. 31, 2009 | 0.1914 |
| Sept. 30, 2009 | 0.1891 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| Dec. 31, 2008 | 0.00 |
| Sept. 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
ONXX Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| WuXi PharmaTech | 0.112 |
| AVEO Pharmaceuticals | 0.00 |
| Celgene Corporation | 0.5628 |
ONXX Debt to Equity Ratio Rankings
| Overall |
74th percentile 2042 of 8005 |
| Sector |
52nd percentile 324 of 686 in Healthcare |
| Industry |
44th percentile 137 of 248 in Biotechnology |
ONXX Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.00 | Jun 2008 |
| Maximum | 0.2702 | Sep 2011 |
| Average | 0.1607 |
